Vimarsana
Biggest News Aggregation in the World

Page 5 - Solid Tumor News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Solid Tumor. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Solid Tumor Today - Breaking & Trending Today

Opening The Floodgates: SRC-3's Role In Regulatory T Cell Suppression - Vimarsana News

Opening The Floodgates: SRC-3's Role In Regulatory T Cell Suppression

Understanding the role of an essential protein inside regulatory T cells could be critical in reverse-engineering a treatment for solid tumors.

Source: forbes.com
How Regulatory T Cells Can Reduce Solid Tumors In Mice - Vimarsana News

How Regulatory T Cells Can Reduce Solid Tumors In Mice

Research on regulatory T cells is building towards a durable and long-lasting treatment for many solid cancers.

Source: forbes.com
SELLAS Life Sciences Presents Positive Key Immunobiological - Vimarsana News

SELLAS Life Sciences Presents Positive Key Immunobiological

Median overall survival for GPS and Keytruda® combination was 18.4 Months compared to 13.8 Months in a Keytruda® single agent study (KEYNOTE-028) and 11-14...

BPRDPO-56 by Molecular Targeting Technologies for Solid Tumor: Likelihood of Approval - Vimarsana News

BPRDPO-56 by Molecular Targeting Technologies for Solid Tumor: Likelihood of Approval

BPRDPO-56 is under clinical development by Molecular Targeting Technologies and currently in Phase I for Solid Tumor.

SELLAS Life Sciences to Present Final Data from Phase 1/2 Study of Galinpepimut-S in ... - Vimarsana News

SELLAS Life Sciences to Present Final Data from Phase 1/2 Study of Galinpepimut-S in ...

NEW YORK, Oct. 17, 2023 (GLOBE NEWSWIRE) -- SELLAS Life Sciences Group, Inc. (NASDAQ: SLS) (“SELLAS’’ or the “Company”), a late-stage clinical biopharmaceutical company focused on the development of novel